Annual SG&A
$13.81 M
+$2.01 M+17.03%
31 December 2023
Summary:
Leap Therapeutics annual selling, general & administrative expenses is currently $13.81 million, with the most recent change of +$2.01 million (+17.03%) on 31 December 2023. During the last 3 years, it has risen by +$4.19 million (+43.58%). LPTX annual SG&A is now at all-time high.LPTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.94 M
-$427.00 K-12.68%
30 September 2024
Summary:
Leap Therapeutics quarterly selling, general & administrative expenses is currently $2.94 million, with the most recent change of -$427.00 thousand (-12.68%) on 30 September 2024. Over the past year, it has dropped by -$390.00 thousand (-11.71%). LPTX quarterly SG&A is now -22.71% below its all-time high of $3.80 million, reached on 31 March 2017.LPTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.70 B
-$64.82 M-3.97%
30 September 2024
Summary:
Leap Therapeutics TTM selling, general & administrative expenses is currently -$1.70 billion, with the most recent change of -$64.82 million (-3.97%) on 30 September 2024. Over the past year, it has dropped by -$1.71 billion (-12607.83%). LPTX TTM SG&A is now -3873.82% below its all-time high of $13.81 million, reached on 31 December 2023.LPTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | -11.7% | -10000.0% |
| 3 y3 years | +43.6% | +20.6% | -10000.0% |
| 5 y5 years | +54.8% | +36.7% | -10000.0% |
LPTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.6% | -22.3% | +20.6% | -78.9% | at low |
| 5 y | 5 years | at high | +54.8% | -22.3% | +36.7% | -145.9% | at low |
| alltime | all time | at high | +813.8% | -22.7% | +181.6% | -3873.8% | at low |
Leap Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.94 M(-12.7%) | $12.97 M(-2.9%) |
| June 2024 | - | $3.37 M(-4.5%) | $13.36 M(-1.4%) |
| Mar 2024 | - | $3.53 M(+12.5%) | $13.55 M(-1.9%) |
| Dec 2023 | $13.81 M(+17.0%) | $3.13 M(-5.9%) | $13.81 M(+1.7%) |
| Sept 2023 | - | $3.33 M(-6.4%) | $13.58 M(+1.1%) |
| June 2023 | - | $3.56 M(-6.0%) | $13.44 M(+5.5%) |
| Mar 2023 | - | $3.78 M(+30.1%) | $12.73 M(+7.9%) |
| Dec 2022 | $11.80 M(+9.6%) | $2.91 M(-8.7%) | $11.80 M(+1.0%) |
| Sept 2022 | - | $3.19 M(+11.6%) | $11.68 M(+6.8%) |
| June 2022 | - | $2.85 M(+0.2%) | $10.93 M(+0.6%) |
| Mar 2022 | - | $2.85 M(+2.0%) | $10.87 M(+1.0%) |
| Dec 2021 | $10.77 M(+12.0%) | $2.79 M(+14.6%) | $10.77 M(+3.5%) |
| Sept 2021 | - | $2.44 M(-12.8%) | $10.40 M(-0.7%) |
| June 2021 | - | $2.79 M(+2.0%) | $10.48 M(+2.7%) |
| Mar 2021 | - | $2.74 M(+12.9%) | $10.20 M(+6.1%) |
| Dec 2020 | $9.62 M(+5.8%) | $2.43 M(-3.4%) | $9.62 M(-1.8%) |
| Sept 2020 | - | $2.51 M(-0.3%) | $9.79 M(+3.8%) |
| June 2020 | - | $2.52 M(+17.1%) | $9.43 M(+2.1%) |
| Mar 2020 | - | $2.15 M(-17.3%) | $9.23 M(+1.6%) |
| Dec 2019 | $9.09 M(+1.8%) | $2.60 M(+21.1%) | $9.09 M(+6.3%) |
| Sept 2019 | - | $2.15 M(-7.5%) | $8.54 M(+0.1%) |
| June 2019 | - | $2.33 M(+16.0%) | $8.54 M(-3.2%) |
| Mar 2019 | - | $2.00 M(-2.8%) | $8.81 M(-1.2%) |
| Dec 2018 | $8.92 M | $2.06 M(-3.7%) | $8.92 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $2.14 M(-17.7%) | $8.99 M(+4.2%) |
| June 2018 | - | $2.60 M(+23.2%) | $8.63 M(+5.7%) |
| Mar 2018 | - | $2.11 M(-0.8%) | $8.16 M(-17.2%) |
| Dec 2017 | $9.85 M(+145.5%) | $2.13 M(+19.7%) | $9.85 M(+19.6%) |
| Sept 2017 | - | $1.78 M(-16.6%) | $8.24 M(+5.3%) |
| June 2017 | - | $2.13 M(-43.9%) | $7.83 M(+15.8%) |
| Mar 2017 | - | $3.80 M(+635.8%) | $6.76 M(+68.5%) |
| Dec 2016 | $4.01 M(+165.5%) | $517.00 K(-62.2%) | $4.01 M(-3747.3%) |
| Sept 2016 | - | $1.37 M(+27.9%) | -$110.00 K(-218.3%) |
| June 2016 | - | $1.07 M(+1.3%) | $93.00 K(-90.3%) |
| Mar 2016 | - | $1.06 M(-129.3%) | $955.00 K(-36.8%) |
| Dec 2015 | $1.51 M(-71.9%) | -$3.60 M(-329.3%) | $1.51 M(-78.3%) |
| Sept 2015 | - | $1.57 M(-18.6%) | $6.98 M(-1.6%) |
| June 2015 | - | $1.93 M(+19.9%) | $7.09 M(+12.1%) |
| Mar 2015 | - | $1.61 M(-13.4%) | $6.33 M(+17.8%) |
| Dec 2014 | $5.37 M(+17.7%) | $1.86 M(+10.2%) | $5.37 M(+23.6%) |
| Sept 2014 | - | $1.69 M(+44.6%) | $4.35 M(-22.3%) |
| June 2014 | - | $1.17 M(+78.3%) | $5.59 M(+12.2%) |
| Mar 2014 | - | $655.00 K(-21.6%) | $4.98 M(+6.2%) |
| Dec 2013 | $4.57 M(+180.0%) | $835.00 K(-71.5%) | $4.70 M(+21.6%) |
| Sept 2013 | - | $2.93 M(+422.8%) | $3.86 M(+316.4%) |
| June 2013 | - | $561.00 K(+53.3%) | $927.00 K(+153.3%) |
| Mar 2013 | - | $366.00 K | $366.00 K |
| Dec 2012 | $1.63 M | - | - |
FAQ
- What is Leap Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Leap Therapeutics?
- What is Leap Therapeutics annual SG&A year-on-year change?
- What is Leap Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Leap Therapeutics?
- What is Leap Therapeutics quarterly SG&A year-on-year change?
- What is Leap Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Leap Therapeutics?
- What is Leap Therapeutics TTM SG&A year-on-year change?
What is Leap Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of LPTX is $13.81 M
What is the all time high annual SG&A for Leap Therapeutics?
Leap Therapeutics all-time high annual selling, general & administrative expenses is $13.81 M
What is Leap Therapeutics annual SG&A year-on-year change?
Over the past year, LPTX annual selling, general & administrative expenses has changed by +$2.01 M (+17.03%)
What is Leap Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of LPTX is $2.94 M
What is the all time high quarterly SG&A for Leap Therapeutics?
Leap Therapeutics all-time high quarterly selling, general & administrative expenses is $3.80 M
What is Leap Therapeutics quarterly SG&A year-on-year change?
Over the past year, LPTX quarterly selling, general & administrative expenses has changed by -$390.00 K (-11.71%)
What is Leap Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of LPTX is -$1.70 B
What is the all time high TTM SG&A for Leap Therapeutics?
Leap Therapeutics all-time high TTM selling, general & administrative expenses is $13.81 M
What is Leap Therapeutics TTM SG&A year-on-year change?
Over the past year, LPTX TTM selling, general & administrative expenses has changed by -$1.71 B (-12607.83%)